Quick Takeaways
- This page summarizes Glenn A. Eisenberg's Form 4 filing for LABORATORY CORP OF AMERICA HOLDINGS (LH).
- 5 reported transactions and 3 derivative rows are listed below.
- Filing timestamp: 03 Nov 2022, 17:04.
Glenn A. Eisenberg - 01 Nov 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)
- Signature
- /s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg
- Issuer symbol
- LH
- Transactions as of
- 01 Nov 2022
- Net transactions value
- -$1,190,251
- Form type
- 4
- Filing time
- 03 Nov 2022, 17:04:30 UTC
- Previous filing
- 28 Sep 2022
- Next filing
- 06 Feb 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Glenn A. Eisenberg filed Form 4 for LABORATORY CORP OF AMERICA HOLDINGS (LH) on 03 Nov 2022."
What Changed
- Previous filing in this sequence was filed on 28 Sep 2022.
- Current net transaction value: -$1,190,251.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LH | Common Stock | Options Exercise | +12,032 | +44% | 39,190 | 01 Nov 2022 | Direct | F1 | ||
| transaction | LH | Common Stock | Tax liability | $1,190,251 | -5,348 | -14% | $222.56 | 33,842 | 01 Nov 2022 | Direct | F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LH | Performance Share Unit | Award | $0 | +9,170 | $0.000000 | 9,170 | 01 Nov 2022 | Common Stock | 9,170 | Direct | F3, F4, F5 | ||
| transaction | LH | Restricted Stock Unit | Award | $0 | +9,170 | +55% | $0.000000 | 25,876 | 01 Nov 2022 | Common Stock | 9,170 | Direct | F1, F6 | |
| transaction | LH | Restricted Stock Unit | Options Exercise | $0 | -12,032 | -46% | $0.000000 | 13,844 | 01 Nov 2022 | Common Stock | 12,032 | Direct | F1, F7, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| F2 | Stock withholding to satisfy tax withholding obligations. |
| F3 | Performance Share Unit granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. |
| F4 | Each Performance Share Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
| F5 | The Performance Share Units vest in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and a performance condition related to the Issuer's contemplated spin-off transaction. |
| F6 | The Restricted Stock Units vest in full on April 15, 2024. |
| F7 | The Restricted Stock Units that have vested were part of a grant that vested in three installments as follows: 30% of the Restricted Stock Units vested on November 1, 2020; 30% of the Restricted Stock Units vested on November 1, 2021; and 40% of the Restricted Stock Units vested on November 1, 2022, with the third installment subject to a relative total shareholder return ("TSR") modifier that could have adjusted the third installment of the Restricted Stock Units upward or downward 25% based on our three-year cumulative relative TSR but ultimately did not result in an adjustment. |
| F8 | This number reflects the aggregate number of Restricted Stock Units held by the reporting person. |